Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas

SANGAMO THERAPEUTICS ENTERS INTO ASSET SALE AGREEMENTS WITH LILLY AND ASTELLAS

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.